Navigation Links
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card
Date:11/23/2009

SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pain and inflammation associated with primary dysmenorrhea and acute tendinitis and bursitis. It is also designed for patients suffering from rheumatoid arthritis or osteoarthritis who may be receiving other therapies and need additional anti-inflammatory/analgesic activity for a limited time. The Dose Card provides a ten day, tapered dose regimen in a single blister pack, with three days of NAPRELAN therapy at the maximum daily dose of 1,500 mg (i.e., two 750 mg tablets), followed by a taper to 1,000 mg per day (two 500 mg tablets) for an additional seven days of therapy.

Commenting on NAPRELAN Dose Card, Victory's Chief Executive Officer Matthew Heck stated, "This product concept is the result of substantial input from our clinical advisors and other members of the pain management community. It was designed to enable healthcare providers to treat pain and inflammation aggressively for a limited period of time and then taper NAPRELAN back to a standard dosage strength. This customized dosage regimen in a single prescription and product configuration will aid in patient compliance. We are excited about the prospects for NAPRELAN Dose Card based upon market feedback."

Victory will promote NAPRELAN Dose Card through its 160 person U.S. field sales organization.

About Victory Pharma

Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring, developing, and marketing products to treat pain and related conditions. Victory markets its lead product, NAPRELAN® (naproxen sodium) Controlled-Release Tablets and other pain products to pain management specialists, rheumatologists, orthopedic surgeons, and selected primary care physicians through its physician office-based field sales force. Victory is also developing proprietary products for the treatment of chronic pain and common opioid-induced side effects. Further information regarding Victory Pharma is available at www.victorypharma.com.

NAPRELAN ® is a trademark of Elan Corporation, plc.

SOURCE Victory Pharma, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers notch a victory toward new kind of cancer drug
2. Stupak Amendment Passes in Final House Health Care Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.
3. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
4. Mother & Daughter Celebrate Victory Over Meth
5. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
6. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
7. President Obama Delivers Historic Victory for Americas Kids and Health over Tobacco
8. American College of Chest Physicians Celebrates the Nations Victory for Tobacco Control
9. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... NY (PRWEB) , ... January 17, 2017 , ... ... Magazine’s fastest-growing private companies and ranked among the top US security companies for ... of Directors. This announcement brings a year-long independent board nomination process to ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Montclair State University’s Athletic Training Education program forged a relationship built upon the ... Education Program, which is consists of both student members and certified members of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... California Southern University ... has served on CalSouthern’s Board of Trustees and as a core faculty member, teaching ... has been a professor of psychology at Pepperdine University, where he earned his Doctor ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... With the ... opened on January 8 for use by sports teams and the general public. Built ... volleyball courts that can also be converted into basketball or pickleball courts. The space ...
(Date:1/16/2017)... Smithtown, New York (PRWEB) , ... January 16, ... ... group, SightMD today announced the addition of Victor Giamos, MD to ... Officer of SightMD and Managing Partner at North Shore Eye Care, a division ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... ROCKLAND, Mass. , Jan. 17, 2017  EMD ... Germany , in the U.S. and ... R. Smith has joined the company as Senior ... In this role, Mr. Smith will oversee the Fertility ... Fertility Technologies division, which launched its first product last ...
(Date:1/17/2017)... -- In a preview of the upcoming Society of Critical Care ... developer of the NephroCheck Test, today highlighted events studying current ... at risk of developing moderate to severe acute kidney injury ... Hawaii Convention Center in ... AKI is one of the top 10 hospital in-patient ...
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
Breaking Medicine Technology: